International Association for Hospice and Palliative Care (IAHPC),
Pain & Policy Studies Group, Univ of Wisconsin / WHO Collaborating
Center for Pain Policy and Palliative Care (PPSG),
[view the 60 launch partners...]
African Palliative Care Association (APCA),
American Cancer Society (ACS),
Argentine Program of Palliative Medicine - Foundation FEMEBA (PAMP-FF),
Asia Pacific Hospice Palliative Care Network (APHN),
Association for Palliative Medicine of Great Britain and Ireland (APM),
Cairdeas International Palliative Care Trust,
Centre for Palliative Care,
Centre for Palliative Care, Nigeria,
Danish Association for Palliative Medicine (DSPaM),
Eastern and Central Europe Palliative Care Task Force (ECEPT),
European Association for Palliative Care (EAPC)
(representing 48 national associations from 29 European countries),
European Society for Medical Oncology (ESMO),
Foundation for Hospices in Sub-Saharan Africa (FHSSA),
French Society of Palliative Care (SFAP),
German Association for Palliative Medicine,
Hellenic Society for Palliative and Symptomatic Care for Cancer and Non Cancer Patients (HSPSCCNCP),
Help the Hospices (HtH),
Hong Kong Society for Palliative Medicine (HKSPM),
Hospice and Palliative Care Association of Nigeria (HPCAN),
Hospice of the Good Shepherd,
Hospice Palliative Care Association of South Africa (HPCA)
Hospice Unit, University College Hospital, Nigeria,
Human Rights Watch (HRW),
Hungarian Hospice Palliative Association (HHPA),
Indian Association for Palliative Care (IAPC),
Institute for Palliative Medicine at San Diego Hospice,
International Association for the Study of Pain (IASP),
International Children’s Palliative Care Network (ICPCN),
International Network for Cancer Treatment and Research (INCTR),
International Observatory on End of Life Care (IOELC),
International Society of Nurses in Cancer Care (ISNCC),
Irish Association for Palliative Care (IAPC Irl),
Italian Society of Palliative Care (SICP),
Kenya Hospices and Palliative Care Association (KEHPCA),
Latin America Association for Palliative Care (ALCP),
Latvian Palliative Care Association (PALL),
Moroccan Society of Palliative Care,
Mozambique Palliative Care Association (MOPCA),
Norwegian Palliative Association (NPA),
Pain Relief and Palliative Care Society - Hyderabad (PRPCS),
Palliative Care Association of Malawi,
Palliative Care Association of Uganda,
Palliative Care Australia,
Polish Society of Palliative Medicine (PTMP),
Portuguese Association for Palliative Care (APCP),
Qualy Observatory, WHO Collaborating Centre for Public Health Palliative Care Programs, Catalan Institute of Oncology,
Romanian Palliative Care Association (ANIP),
Swedish Association of Palliative Medicine,
Swiss Association for Palliative Care,
Tanzania Palliative Care Association,
Ukrainian League of Palliative and Hospice Care Development (LHPCDU),
Union for International Cancer Control (UICC) and,
University of Edinburgh – College of Medicine,
University of Texas M.D. Anderson Cancer Center,
University of Utah Pain Management Center,
Victoria Hospice and
WHO Collaborating Centre for Palliative Care, Oxford, UK
Worldwide Palliative Care Alliance (WPCA),
Considering that the 2011 United Nations political declaration on non-communicable diseases calls for member states to promote the use of affordable medicines, including generics, for palliative care;1
Considering the World Health Organization’s recommendation that essential medicines should be available to patients at all times and at a price the individual and the community can afford;2
Recognizing that morphine is the only strong opioid analgesic included in the WHO Model List of Essential Medicines;3
Finding that immediate release oral morphine is less expensive for patients than sustained release morphine and most other strong opioid formulations;6
Aware that in many institutions, particularly in low and low-middle income countries, immediate release oral morphine is not available, while opioid formulations that are more expensive (or more difficult to use, such as injectable morphine) are available;
Considering that the high cost of opioids hinders access to treatment to the vast majority of patients in many low and low-middle income countries, resulting in millions of patients suffering needlessly with untreated pain;
Recognizing that the low profit margin typically realized from selling immediate release oral morphine is often made worse by the additional costs of unnecessarily burdensome regulatory requirements, which may further deter the pharmaceutical industry from supplying immediate release morphine,
DECLARE that denial of adequate pain treatment to significant numbers of patients violates the right to the highest attainable standard of physical and mental health, as articulated in article 12 of the International Covenant on Economic, Social and Cultural Rights,7 and may violate the prohibition of cruel, inhuman, or degrading treatment8 as articulated in article 7 of the International Covenant on Civil and Political Rights;9 and
DECLARE that the exclusive availability of sustained release morphine and other expensive or injectable opioid formulations hinders access to an essential health service, leading to poor clinical and public health practice.
WE CALL UPON GOVERNMENTS, PHARMACEUTICAL INDUSTRY AND HEALTH CARE INSTITUTIONS to guarantee the accessibility of immediate release oral morphine to patients in need at a cost that the individual and community can afford. In particular:
(1) United Nations General Assembly. Political declaration of the High-level Meeting of the General Assembly on the Prevention and Control of Non-communicable Diseases. Draft resolution submitted by the President of the General Assembly at the sixty-sixth session; Agenda item 117; September. 2011. New York, NY, United Nations.
(2) World Health Organization. Essential medicines (website). 2005; Available from: http://www.who.int/topics/essential_medicines/en/. Accessed October 10, 2011.
(3) World Health Organization. Essential Medicines – WHO Model List. 17th ed. Geneva, Switzerland: World Health Organization, 2011.
(4) Hanks GW, De Conno F, Cherny N et al. Morphine and alternative opioids in cancer pain: the EAPC recommendations. British Journal of Cancer 2001;84:587-593.
(5) Caraceni A, Pigni A, Brunelli C. Is oral morphine still the first choice opioid for moderate to severe cancer pain? A systematic review within the European Palliative Care Research Collaborative guidelines project. Palliat Med 2011;25:402-409.
(6) De Lima L, Sweeney C, Palmer JL, Bruera E. Potent analgesics are more expensive for patients in developing countries: A comparative study. J Pain Palliat Care Pharmacother 2004;18:59-70.
(7) United Nations General Assembly. International Covenant on Economic, Social and Cultural Rights. Adopted at the 1496th U.N. General Assembly plenary meeting, 16 December 1966; entered into force 3 January 1976. 1966. New York, NY, United Nations.
(8) Lohman D, Schleifer R, Amon JJ. Access to pain treatment as a human right. BioMed Central Medicine 2010;8:8.
(9) United Nations General Assembly. The Universal Declaration of Human Rights. Adopted at the 181st U.N. General Assembly plenary meeting by Resolution 217 A (III), 10 December 1948; Paris, France. 1948. http://www.un.org/en/documents/udhr/index.shtml, United Nations.